Multiple sclerosis
Typical clinical and paraclinical evidence with characteristic dissemination and no better explanation.
Diagnosis & MRI
Contents
There is no single symptom, scan, or blood test that diagnoses multiple sclerosis by itself. The workup asks whether the history and examination fit a central nervous system demyelinating disorder, whether objective evidence is distributed in a characteristic way, and whether another diagnosis explains the findings better.
Diagnostic synthesis combines a compatible presentation, lesion distribution, temporal evidence, biomarkers, and exclusion of a better explanation. The published McDonald criteria organize that evidence, but correct application still depends on clinical judgment.
Imaging gallery
AI-generated educational schematic. Not a real medical image or an exact anatomical representation.
Brain MRI assesses lesion location, morphology, enhancement, and interval change.
AI-generated educational schematic. Not a real medical image or an exact anatomical representation.
Spinal imaging can identify cord lesions and evaluate structural alternatives.
AI-generated educational schematic. Not a real medical image or an exact anatomical representation.
CSF can provide evidence of intrathecal immune activity but does not diagnose MS in isolation.
Differential diagnosis
NMOSD
Aquaporin-4 antibody-associated disease can require different long-term treatment and must not be mislabeled as MS.
MOGAD
MOG antibody-associated optic neuritis, myelitis, or brain inflammation has overlapping but distinct patterns.
Vascular or migraine-related lesions
Nonspecific white-matter lesions require interpretation by location, morphology, age, risk factors, and symptoms.
Infectious or systemic inflammatory disease
History, examination, blood and CSF studies, imaging, and systemic findings may identify another mechanism.
Structural or metabolic disease
Compression, deficiency, toxic injury, and inherited disorders can mimic selected clinical or imaging features.
MRI evaluates the brain and, when indicated, the spinal cord and optic nerves. Specialists assess lesion location, morphology, enhancement, and change over time rather than counting all white-matter spots equally. Standardized acquisition improves comparison across visits. [1]
Cerebrospinal fluid and optic nerve evidence
Section titled “Cerebrospinal fluid and optic nerve evidence”A lumbar puncture may assess CSF-specific oligoclonal bands or kappa free light chains, cell count, protein, and tests for alternative diagnoses. Objective optic nerve evidence may come from MRI, optical coherence tomography, or visual evoked potentials in defined circumstances.
Applying diagnostic criteria
Section titled “Applying diagnostic criteria”The 2024 criteria include the optic nerve as a fifth central nervous system location and provide roles for CSF and susceptibility-based markers such as the central vein sign and paramagnetic rim lesions. They also address selected people with radiologically isolated findings. These additions do not remove the need for a compatible context and careful exclusion of mimics. [2]
Clinical detail
Section titled “Clinical detail”Diagnostic certainty depends on data quality. MRI field strength, sequence, slice thickness, motion, lesion location, prior scans, steroid timing, and gadolinium use can affect interpretation. Atypical symptoms or imaging should increase, not lower, attention to alternative diagnoses.